These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 31769569)
1. Successful treatment of fulminant Clostridioides difficile infection with emergent fecal microbiota transplantation in a patient with acute myeloid leukemia and prolonged, severe neutropenia. Lee MSL; Ramakrishna B; Moss AC; Gold HS; Branch-Elliman W Transpl Infect Dis; 2020 Feb; 22(1):e13216. PubMed ID: 31769569 [TBL] [Abstract][Full Text] [Related]
2. Fecal microbiota transplantation for recurrent Clostridium difficile infection in hematopoietic stem cell transplant recipients. Webb BJ; Brunner A; Ford CD; Gazdik MA; Petersen FB; Hoda D Transpl Infect Dis; 2016 Aug; 18(4):628-33. PubMed ID: 27214585 [TBL] [Abstract][Full Text] [Related]
3. Successful use of early, repeat fecal microbiota transplantation for initial treatment of severe, refractory Clostridioides difficile colitis. Cappetto CM Am J Health Syst Pharm; 2021 Jul; 78(15):1374-1381. PubMed ID: 33851215 [TBL] [Abstract][Full Text] [Related]
4. Systematic Review with Meta-Analysis: Fecal Microbiota Transplantation for Severe or Fulminant Clostridioides difficile. Tixier EN; Verheyen E; Luo Y; Grinspan LT; Du CH; Ungaro RC; Walsh S; Grinspan AM Dig Dis Sci; 2022 Mar; 67(3):978-988. PubMed ID: 33748913 [TBL] [Abstract][Full Text] [Related]
5. Expert opinion on fecal microbiota transplantation for the treatment of Kumar V; Fischer M Expert Opin Biol Ther; 2020 Jan; 20(1):73-81. PubMed ID: 31690143 [No Abstract] [Full Text] [Related]
6. Long-term durability and safety of fecal microbiota transplantation for recurrent or refractory Clostridioides difficile infection with or without antibiotic exposure. Lee CH; Chai J; Hammond K; Jeon SR; Patel Y; Goldeh C; Kim P Eur J Clin Microbiol Infect Dis; 2019 Sep; 38(9):1731-1735. PubMed ID: 31165961 [TBL] [Abstract][Full Text] [Related]
8. Clinical management of severe, fulminant, and refractory Cheng YW; Fischer M Expert Rev Anti Infect Ther; 2020 Apr; 18(4):323-333. PubMed ID: 32057278 [No Abstract] [Full Text] [Related]
9. Clinical practice guidelines for Clostridioides (Clostridium) difficile infection and fecal microbiota transplant protocol - recommendations of the Polish Society od Epidemiology and Infectious Diseases. Piekarska A; Panasiuk A; Stępień PM Przegl Epidemiol; 2020; 74(1):69-87. PubMed ID: 32500988 [TBL] [Abstract][Full Text] [Related]
10. Fecal Microbiota Transplant Decreases Mortality in Patients with Refractory Severe or Fulminant Clostridioides difficile Infection. Cheng YW; Phelps E; Nemes S; Rogers N; Sagi S; Bohm M; El-Halabi M; Allegretti JR; Kassam Z; Xu H; Fischer M Clin Gastroenterol Hepatol; 2020 Sep; 18(10):2234-2243.e1. PubMed ID: 31923639 [TBL] [Abstract][Full Text] [Related]
11. Fecal Microbiota Transplantation for Clostridioides difficile in High-Risk Older Adults Is Associated with Early Recurrence. Luo Y; Tixier EN; Grinspan AM Dig Dis Sci; 2020 Dec; 65(12):3647-3651. PubMed ID: 32078714 [TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness analysis of sequential fecal microbiota transplantation for fulminant Clostridioides difficile infection. Gupta S; Zhu J; McCarty TR; Pruce J; Kassam Z; Kelly C; Fischer M; Allegretti JR J Gastroenterol Hepatol; 2021 Sep; 36(9):2432-2440. PubMed ID: 33682170 [TBL] [Abstract][Full Text] [Related]
14. Fecal microbiota transplantation (FMT) for Clostridium difficile infection: focus on immunocompromised patients. Di Bella S; Gouliouris T; Petrosillo N J Infect Chemother; 2015 Apr; 21(4):230-7. PubMed ID: 25703532 [TBL] [Abstract][Full Text] [Related]
15. Fecal microbiota transplantation (FMT) for C. difficile infection, just say 'No'. Tan X; Johnson S Anaerobe; 2019 Dec; 60():102092. PubMed ID: 31472233 [TBL] [Abstract][Full Text] [Related]
16. [Refractory colitis by Clostridium difficile treated with fecal microbiota transplant]. Martínez JV; Raush A; Efrón ED; Zubiaurre I; Pinoni MV; Giorgio PL; Eusebio MJ; Verbanaz SC; Jordan R Medicina (B Aires); 2019; 79(4):291-294. PubMed ID: 31487251 [TBL] [Abstract][Full Text] [Related]
17. Fecal microbiota transplant in severe and severe-complicated Clostridium difficile: A promising treatment approach. Fischer M; Sipe B; Cheng YW; Phelps E; Rogers N; Sagi S; Bohm M; Xu H; Kassam Z Gut Microbes; 2017 May; 8(3):289-302. PubMed ID: 28001467 [TBL] [Abstract][Full Text] [Related]
18. Long-term Follow-up Study of Fecal Microbiota Transplantation for Severe and/or Complicated Clostridium difficile Infection: A Multicenter Experience. Aroniadis OC; Brandt LJ; Greenberg A; Borody T; Kelly CR; Mellow M; Surawicz C; Cagle L; Neshatian L; Stollman N; Giovanelli A; Ray A; Smith R J Clin Gastroenterol; 2016; 50(5):398-402. PubMed ID: 26125460 [TBL] [Abstract][Full Text] [Related]
19. An Infectious Diseases Perspective on Fecal Microbiota Transplantation for Clostridioides difficile Infection in Children. Cotter JM; Nicholson MR; Kociolek LK J Pediatric Infect Dis Soc; 2019 Dec; 8(6):580-584. PubMed ID: 31550348 [TBL] [Abstract][Full Text] [Related]
20. Faecal microbiota transplant decreases mortality in severe and fulminant Clostridioides difficile infection in critically ill patients. Tixier EN; Verheyen E; Ungaro RC; Grinspan AM Aliment Pharmacol Ther; 2019 Nov; 50(10):1094-1099. PubMed ID: 31612528 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]